# CETO First in Human Trial

> **NCT04529018** · NA · UNKNOWN · sponsor: **University of Cambridge** · enrollment: 11 (estimated)

## Conditions studied

- Primary Aldosteronism

## Interventions

- **COMBINATION_PRODUCT:** [18F]CETO

## Key facts

- **NCT ID:** NCT04529018
- **Lead sponsor:** University of Cambridge
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-03
- **Primary completion:** 2020-11-30
- **Final completion:** 2020-11-30
- **Target enrollment:** 11 (ESTIMATED)
- **Last updated:** 2020-08-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04529018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04529018, "CETO First in Human Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04529018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*